You are here: Industry Insights > 2019-nCov

News List

Epidemic Situation of the 2019 Novel Coronavirus Outbreak (Updated on April.28） En-CPhI.Cn
April 21, 2020
The novel coronavirus (2019-nCoV) outbreak continues with confirmed cases of the new coronary pneumonia and death tolls grows in China and around the world.
Interview: China's anti-virus efforts "remarkable," int'l cooperation needed: UN humanitarian chief Xinhuanet
February 17, 2020
China's response to the novel coronavirus outbreak is remarkable and the international community shares a common interest in collaborating to tackle the epidemic, UN Undersecretary-General for Humanitarian Affairs and Emergency Relief Coordinator Mark Low
New infections of novel coronavirus drop for 12th consecutive day outside Hubei Xinhuanet
February 17, 2020
China's daily new confirmed cases of the disease outside Hubei, the epicenter province in the outbreak, have been dropping for 12 consecutive days, according to the National Health Commission Sunday.
A Summary and Interpretation of the Progress of Clinical Trials Relating to the Novel Coronavirus Pneumonia (2) PharmaSources/Zhulikou431
February 14, 2020
The collection time of the information summarized above is Feb. 2, 2020, which will change with the progress of scientific research.
A Summary and Interpretation of the Progress of Clinical Trials Relating to the Novel Coronavirus Pneumonia (1) PharmaSources/zhulikou431
February 14, 2020
The novel coronavirus pneumonia incident that started to occur in Wuhan City, Hubei Province from Dec. 2019 has produced continuous impacts on the Chinese people.
Evolving World of Pharma: Efforts for a coronavirus vaccine Sarah Harding
February 13, 2020
There is an immediate need for medicines that can help treat the acute respiratory disease, as well as the development of an effective vaccine.
Condair study shows indoor humidification can reduce the transmission and risk of infection from Coronavirus PRNewswire
February 12, 2020
The death toll from the Coronavirus 2019-CoV outbreak has now risen to over 1000.
2019 Novel Coronavirus Driving Surging Demand for Disposable Masks, Protective Apparel, & Related Medical Supplies in China PRNewswire
February 12, 2020
The 2019 novel coronavirus is driving a surge in demand for disposable medical supplies in China, where the market totaled $27.2 billion in 2017, according to a Freedonia Group analysis.
Experimental antiviral Drug Remdesivir recognized as potential treatment for 2019-nCov PharmaSources
February 10, 2020
Remdesivir, an experimental antiviral drug, has been recognized as a potential treatment against the 2019 novel-Coronavirus (2019-nCov) recently outbreaks in China and around the world.
Gilead Sciences Statement on the Company’s Ongoing Response to the 2019 Novel Coronavirus (2019-nCoV) Gilead Sciences
February 01, 2020
Gilead Sciences today issued the following statement the Company’s Ongoing Response to the 2019 Novel Coronavirus (2019-nCoV).

Previous page 1 2 Next page